ACADIA Pharmaceuticals (ACAD) Bɛn Dɛŋɛn Akɔc
Bɛ̈ny cɔk aya$20.68Aciic 25 Sep 2026 19:59 UTC
Change-6.76%
AI forecast: ACAD
AI ekek aŋok wɛlɛɛl bɛn bɛn lɔŋɔŋ, bɛn bɛn cɔlɔŋ, kɛ bɛn bɛn cɔlɔŋ. Cɔkɔkɔkɔ cɔlɔŋ bɛn bɛn lɔŋɔŋ. Aŋok wɛlɛɛl aŋok wɛlɛɛl, aŋok wɛlɛɛl aŋok wɛlɛɛl.
Bɛn cɔk ɛcɔk 6
Premium shows the AI's price targets for 1 day, 1 week and 1 month for this and every other stock.
Unlock Premium🔒 Nyɛn cɔk aya bɛn
Ditëëk ë bɛ̈ɛ̈r ë cë lɔ – ditëëk ë cë lɔ kee aköl aköl ë bɛ̈ɛ̈r ë cë lɔ – aye Premium.
Unlock PremiumBɛn kɔc ke bɛn
ACADIA Pharmaceuticals Inc. is a biopharmaceutical company specializing in the development and commercialization of small-molecule drugs for the treatment of central nervous system disorders, including dysfunctions caused by Parkinson’s disease, schizophrenia, neuropathic pain, and glaucoma.
